Home - IsoPlexis
14869
home,page,page-id-14869,page-template,page-template-full_width,page-template-full_width-php,,qode-title-hidden,qode-theme-ver-9.1.2,wpb-js-composer js-comp-ver-4.7.4,vc_responsive

who we are


t-cell

cellular function matters to us

At IsoPlexis, big data meets cellular specificity: we find key differences among T-cells that drive response to therapy and disease

leadership-icon

developed with leaders in the field

Our founding board and scientific advisory board bring together the best ideas in immunology & oncology from a nationwide ecosystem

data

next generation immunology

Our cutting-edge technology and analytics platform shed a revealing light on the cell subsets responsible for patient outcomes

our solution

our single-cell solution helps researchers and clinicians find the immune cell subsets driving patient immune response


Our Solution

home-our-solution

publications in peer reviewed journals

PNAS-LOGO

Highly Multiplexed Profiling of Single-cell Function Reveals Deep Functional Heterogeneity in Response to Pathogenic Ligands

read more
CD-LOGO

Multifunctional T-cell Analyses to Study Response and Progression in Adoptive Cell Transfer Immunotherapy

read more
CD-LOGO

JAK-STAT Pathway Activation in Malignant and Non-Malignant Cells Contributes to MPN Pathogenesis and Therapeutic Response

Read More

latest news

Financing

Spring Mountain Capital

Spring Mountain Capital leads growth equity investment in IsoPlexis.

read more

Applications

Stand up to Cancer

Groundbreaking analysis is helping advance therapeutic success.

read more

Leadership

Scientific Advisory Board

IsoPlexis appoints academic and industry experts to inaugural Scientific Advisory Board.

read more

sponsored by

NIH-Logo
NCI-Logo